NEOGENOMICS INC — Director's Dealing 2020

Dec 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-12-14

Reporting Person: Weiss Lawrence Martin (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-14	Common Stock	M	50000	$6.98	Acquired	61717	Direct
2020-12-14	Common Stock	M	20000	$7.27	Acquired	81717	Direct
2020-12-14	Common Stock	M	13333	$9.22	Acquired	95050	Direct
2020-12-14	Common Stock	M	16666	$13.87	Acquired	111716	Direct
2020-12-14	Common Stock	M	9005	$19.60	Acquired	120721	Direct
2020-12-14	Common Stock	S	20200	$51.06	Disposed	100521	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-14	Stock Option (Right to Buy)	$6.98	M	50000	Disposed	2021-03-01	Common Stock (50000.0)	Direct
2020-12-14	Stock Option (Right to Buy)	$7.27	M	20000	Disposed	2022-05-25	Common Stock (20000.0)	Direct
2020-12-14	Stock Option (Right to Buy)	$9.22	M	13333	Disposed	2023-04-19	Common Stock (13333.0)	Direct
2020-12-14	Stock Option (Right to Buy)	$13.87	M	16666	Disposed	2023-12-12	Common Stock (16666.0)	Direct
2020-12-14	Stock Option (Right to Buy)	$19.6	M	9005	Disposed	2024-03-01	Common Stock (9005.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$28.33	2027-03-02	Common Stock (37514.0)	37514	Direct

Footnotes

F1: On March 1, 2016, Dr. Weiss was granted 50,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.

F2: On May 25, 2017, Dr. Weiss was granted 20,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.

F3: On April 19, 2018, Dr. Weiss was granted 20,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F4: On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F5: On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F6: On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.